Vasculitis Trial, Recruiting (NCT07086989)

Vasculitis Trial, Recruiting NCT07086989 Sponsor: Semmelweis University Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT07086989 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 6 and 25 years old
You have been diagnosed with a long-term childhood health condition that is known to increase the risk of developing heart disease at an early age (confirm with trial site for whether your specific condition qualifies)
You are aged 18 or over and are able to give your own consent to take part, or you are under 18 and a parent or legal guardian is able to give consent on your behalf

Who may not be able to join:

You have a severe intellectual or developmental disability
You currently have serious, unstable heart failure
You have a severe condition that significantly weakens your immune system from birth
You are currently receiving chemotherapy given through a drip or injection into a vein
You have an infectious disease that is considered a risk to public health
You have a history of regularly using alcohol or drugs

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tamas Kiss, MD, PhD, Semmelweis University, Pediatric Center

Phone: +36202478885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07086989

Sponsor: Semmelweis University

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +36202478885

More information: https://clinicaltrials.gov/study/NCT07086989

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 6 and 25 years old
You have been diagnosed with a long-term childhood health condition that is known to increase the risk of developing heart disease at an early age (confirm with trial site for whether your specific condition qualifies)
You are aged 18 or over and are able to give your own consent to take part, or you are under 18 and a parent or legal guardian is able to give consent on your behalf

Who may not be able to join:

You have a severe intellectual or developmental disability
You currently have serious, unstable heart failure
You have a severe condition that significantly weakens your immune system from birth
You are currently receiving chemotherapy given through a drip or injection into a vein
You have an infectious disease that is considered a risk to public health
You have a history of regularly using alcohol or drugs

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Semmelweis University

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

31 January 2029

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Arterial stiffness; Endothelial function of the brachial artery; Retinal vessel diameter; Retinal vessel fractal dimension and tortuosity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov